For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Botulinum toxin type A - Hypersalivation in children
PAD Profile : Botulinum toxin type A - Hypersalivation in children
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
- Migraine (prevention)
- Movement disorders
- Gastroparesis
- Pyloric spasm (post GI surgery)
- Facial spasm
- Protective ptosis and squint
- Chronic sialorrhoea
Additional Documents
No additional documents returned.
Committee Recommendations
This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.
This drug has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicans can contact syheartlandsccg.APC@nhs.net if they wish to make a submission.